Clinical Trial Update: Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating albumin-bound paclitaxel with gemcitabine in untreated stage IV or recurrent squamous cell lung cancer; results posted in 2020…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Squamous Cell Lung Cancer

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer, Untreated Stage IV or Recurrent Squamous Cell Lung Cancers | Phase 2 | Status: COMPLETED | Results posted: 2020-05-08